Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.
Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, Rabinovich GA.
Salatino M, et al.
Expert Opin Biol Ther. 2008 Jan;8(1):45-57. doi: 10.1517/14712598.8.1.45.
Expert Opin Biol Ther. 2008.
PMID: 18081536
Review.
This endogenous lectin widely expressed at sites of inflammation and tumour growth, has been postulated as an attractive immunosuppressive agent to restore immune cell tolerance and homeostasis in autoimmune and inflammatory settings. On the other hand, galectin- …
This endogenous lectin widely expressed at sites of inflammation and tumour growth, has been postulated as an attractive immunosuppressive a …